PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
14-Jan-2020 Phio Pharmaceuticals Announces Reverse Stock Split Phio Pharmaceuticals Corp.
14-Jan-2020 Foamix Announces AMZEEQ(TM) (minocycline) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S. Foamix Pharmaceuticals Ltd.
14-Jan-2020 CNS Pharmaceuticals Announces Contract with International GMP Manufacturer for Production of Berubicin CNS Pharmaceuticals, Inc.
14-Jan-2020 ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule B3C newswire
14-Jan-2020 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG publishes annual report for financial year 2018/19 B.R.A.I.N. Biotechnology Research And Information Network AG
14-Jan-2020 JUST - EVOTEC BIOLOGICS ENTERS INTO MULTI-YEAR COLLABORATION WITH MSD AROUND FACILITY OF THE FUTURE Evotec SE
14-Jan-2020 JUST - EVOTEC BIOLOGICS INITIATES CONSTRUCTION OF FIRST J.POD(R) FACILITY IN NORTH AMERICA Evotec SE
14-Jan-2020 Vivoryon Therapeutics AG: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration Vivoryon Therapeutics AG
14-Jan-2020 Biofrontera AG: Biofrontera announces 1-year follow-up results for its phase III study of photodynamic therapy for actinic keratosis on the extremities and trunk/neck Biofrontera AG
14-Jan-2020 Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada Innovent Biologics, Inc.
14-Jan-2020 Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Genome & Company
14-Jan-2020 Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada Innovent Biologics, Inc.
14-Jan-2020 Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Genome & Company
13-Jan-2020 Vanda Pharmaceuticals Wins Key U.S. Supreme Court Patent Ruling on Fanapt® Vanda Pharmaceuticals Inc.
13-Jan-2020 Hansa Biopharma provides business update ahead of the JP Morgan Global Healthcare Conference Hansa Biopharma
13-Jan-2020 BioMed X Starts New Schizophrenia Research Program with Boehringer Ingelheim B3C newswire
13-Jan-2020 HRA PHARMA FURTHERS INTERNATIONAL EXPANSION WITH CHINESE JOINT VENTURE HRA Pharma
13-Jan-2020 Exosomics implements NanoFCM’s NanoAnalyzer at its Siena facility to provide advanced extracellular vesicles-focused analytical services NanoFCM
13-Jan-2020 apceth Starts Commercial Manufacturing of Zynteglo™ ▼, bluebird bio’s Gene Therapy for Transfusion-Dependent β-Thalassemia B3C newswire
13-Jan-2020 Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences Kyverna Therapeutics